Article
A possible advance in arterial gene therapy for aortic complications in the Marfan syndrome by local transfer of an antisense Mg-dependent hammerhead ribozyme.
Magnesium research - 1 Mar 2001
Durlach J
Abstract excerpt
Aortic dissection and rupture make the Marfan Syndrome (MFS), one of the most highly lethal genetic condition, but these events are preceded by simple aortic root dilatation over a long period. A hydrogel coated angioplasty balloon might constitute a possible aortic vector to locally deliver an antisense Mg-dependent hammerhead ribozyme capable to control specifically the genetic alteration of fibrillin 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
